首页 > 最新文献

Drug and Therapeutics Bulletin最新文献

英文 中文
Recent updates from the BNF (BNF 86). BNF的最新更新(BNF 86)。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-09-25 DOI: 10.1136/dtb.2023.000050

The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some of the key changes that have been made to BNF content.

BNF由英国皇家药学会和英国医学杂志联合出版。BNF每年出版两次印刷版,中期更新每月以数字版本发布。以下摘要简要介绍了对BNF内容所做的一些关键更改。
{"title":"Recent updates from the <i>BNF</i> (<i>BNF 86</i>).","authors":"","doi":"10.1136/dtb.2023.000050","DOIUrl":"10.1136/dtb.2023.000050","url":null,"abstract":"<p><p>The <i>BNF</i> is jointly published by the Royal Pharmaceutical Society and BMJ. <i>BNF</i> is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some of the key changes that have been made to <i>BNF</i> content.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"166-167"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41114524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Missing information in US accelerated approval drug labels. 美国加速审批药品标签中缺少信息。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-09-21 DOI: 10.1136/dtb.2023.000047

Overview of: Ballreich J, Socal M, Bennett CL, et al. Accelerated approval drug labels often lack information for clinical decision-making. Pharmacotherapy 2023;43:300-4.

综述:Ballreich J,Socal M,Bennett CL等人。加速批准药物标签通常缺乏临床决策信息。药物治疗2023;43:30-4。
{"title":"Missing information in US accelerated approval drug labels.","authors":"","doi":"10.1136/dtb.2023.000047","DOIUrl":"10.1136/dtb.2023.000047","url":null,"abstract":"<p><p><b>Overview of:</b> Ballreich J, Socal M, Bennett CL, et al. Accelerated approval drug labels often lack information for clinical decision-making. <i>Pharmacotherapy</i> 2023;43:300-4.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"164"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure associated with ustekinumab therapy for treatment of Crohn's Disease. 与ustekinumab治疗克罗恩病相关的心力衰竭。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-06-30 DOI: 10.1136/dtb.2023.250376rep
Erica Morgenweck, Brian Park, Richard Bower
A man in his 60s with penetrating ileocolonic Crohn’s disease (CD), recently started on ustekinumab therapy, presented with new onset dyspnoea, paroxysmal nocturnal dyspnoea and dependent oedema. He was diagnosed with heart failure (HF) 10 months after starting ustekinumab therapy. His symptoms resolved with discontinuation of ustekinumab and he had recovery of his cardiac function. Though initial studies that led to the U.S Food and Drug Administration (FDA)approval for ustekinumab did not detect a signal for HF, postmarketing surveillance has detected rare cases of HF after initiation of the medication. This is one of the few reported cases of HF associated with ustekinumab therapy for CD.
{"title":"Heart failure associated with ustekinumab therapy for treatment of Crohn's Disease.","authors":"Erica Morgenweck,&nbsp;Brian Park,&nbsp;Richard Bower","doi":"10.1136/dtb.2023.250376rep","DOIUrl":"10.1136/dtb.2023.250376rep","url":null,"abstract":"A man in his 60s with penetrating ileocolonic Crohn’s disease (CD), recently started on ustekinumab therapy, presented with new onset dyspnoea, paroxysmal nocturnal dyspnoea and dependent oedema. He was diagnosed with heart failure (HF) 10 months after starting ustekinumab therapy. His symptoms resolved with discontinuation of ustekinumab and he had recovery of his cardiac function. Though initial studies that led to the U.S Food and Drug Administration (FDA)approval for ustekinumab did not detect a signal for HF, postmarketing surveillance has detected rare cases of HF after initiation of the medication. This is one of the few reported cases of HF associated with ustekinumab therapy for CD.","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"173-175"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9746329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction to pharmacogenetics. 药物遗传学导论。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-10-03 DOI: 10.1136/dtb.2023.000009
John Henry McDermott, William Newman

There is considerable interindividual variability in the effectiveness and safety of medicines. Although the reasons for this are multifactorial, it is well recognised that genetic changes impacting the absorption or metabolism of these drugs play a significant contributory role. Understanding how these pharmacogenetic variants impact response to medicines, and leveraging this knowledge to guide prescribing, could have significant benefits for patients and health services. This article provides an introduction to the field of pharmacogenetics, including its nomenclature, the existing evidence base and the current state of implementation globally. We discuss the challenges in translating pharmacogenetic research into clinical practice and highlight the considerable benefits which can emerge in those health services where implementation is successful.

药物的有效性和安全性存在相当大的个体差异。尽管造成这种情况的原因是多因素的,但众所周知,影响这些药物吸收或代谢的基因变化起着重要作用。了解这些药物遗传变异如何影响对药物的反应,并利用这些知识指导处方,可能会对患者和医疗服务产生重大益处。本文介绍了药物遗传学领域,包括其命名法、现有证据基础和全球实施现状。我们讨论了将药物遗传学研究转化为临床实践的挑战,并强调了在成功实施的医疗服务中可能出现的巨大好处。
{"title":"Introduction to pharmacogenetics.","authors":"John Henry McDermott,&nbsp;William Newman","doi":"10.1136/dtb.2023.000009","DOIUrl":"10.1136/dtb.2023.000009","url":null,"abstract":"<p><p>There is considerable interindividual variability in the effectiveness and safety of medicines. Although the reasons for this are multifactorial, it is well recognised that genetic changes impacting the absorption or metabolism of these drugs play a significant contributory role. Understanding how these pharmacogenetic variants impact response to medicines, and leveraging this knowledge to guide prescribing, could have significant benefits for patients and health services. This article provides an introduction to the field of pharmacogenetics, including its nomenclature, the existing evidence base and the current state of implementation globally. We discuss the challenges in translating pharmacogenetic research into clinical practice and highlight the considerable benefits which can emerge in those health services where implementation is successful.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"168-172"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
No benefit of vitamin D on cognition in older adults. 维生素D对老年人的认知没有好处。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-08-24 DOI: 10.1136/dtb.2023.000043

Overview of: Pham H, Waterhouse M, Rahman S, et al. Vitamin D supplementation and cognition- results from analyses of the D-Health trial. J Am Geriatr Soc 2023;7:1773-84.

综述:Pham H,Waterhouse M,Rahman S等。维生素D的补充和认知——来自D-健康试验的分析结果。J Am Geriatr Soc 2023;7:1773-84。
{"title":"No benefit of vitamin D on cognition in older adults.","authors":"","doi":"10.1136/dtb.2023.000043","DOIUrl":"10.1136/dtb.2023.000043","url":null,"abstract":"<p><p><b>Overview of:</b> Pham H, Waterhouse M, Rahman S, et al. Vitamin D supplementation and cognition- results from analyses of the D-Health trial. <i>J Am Geriatr Soc</i> 2023;7:1773-84.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"163"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10057603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coroners' reports, medicines and preventable deaths. 验尸报告、药物和可预防的死亡。
Q4 Medicine Pub Date : 2023-11-01 Epub Date: 2023-09-25 DOI: 10.1136/dtb.2023.000048

Overview of: France hs, aronson JK, heneghan c, et al. preventable deaths involving medicines: a systematic case series of coroners' reports 2013- 22. Drug Saf 2023;46:335-42.

综述:France hs,aronson JK,heneghan c等人。药物可预防的死亡:2013-22年验尸报告的系统病例系列。Drug Saf 2023;46:335-42。
{"title":"Coroners' reports, medicines and preventable deaths.","authors":"","doi":"10.1136/dtb.2023.000048","DOIUrl":"10.1136/dtb.2023.000048","url":null,"abstract":"<p><p><b>Overview of:</b> France hs, aronson JK, heneghan c, et al. preventable deaths involving medicines: a systematic case series of coroners' reports 2013- 22. <i>Drug Saf</i> 2023;46:335-42.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"165"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41108365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moving with the times. 与时俱进。
Q4 Medicine Pub Date : 2023-11-01 DOI: 10.1136/dtb.2023.000055
David Phizackerley
{"title":"Moving with the times.","authors":"David Phizackerley","doi":"10.1136/dtb.2023.000055","DOIUrl":"10.1136/dtb.2023.000055","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":"61 11","pages":"162"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50157300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to treat the climate and nature crisis as one indivisible global health emergency. 是时候将气候和自然危机视为一个不可分割的全球卫生紧急事件了。
Q4 Medicine Pub Date : 2023-10-25 DOI: 10.1136/dtb.2023.000060
{"title":"Time to treat the climate and nature crisis as one indivisible global health emergency.","authors":"","doi":"10.1136/dtb.2023.000060","DOIUrl":"https://doi.org/10.1136/dtb.2023.000060","url":null,"abstract":"","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50161109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intravenous vitamin injections: where is the evidence? 静脉注射维生素:证据在哪里?
Q4 Medicine Pub Date : 2023-10-01 Epub Date: 2023-08-28 DOI: 10.1136/dtb.2023.000006

The body needs small daily quantities of vitamins and minerals, which are usually obtained from the diet. Intravenous vitamins are used for a few serious medical conditions (eg, malabsorption syndromes with severe vitamin depletion, Wernicke's encephalopathy or critical illness). Intravenous drips containing high doses of various vitamins and minerals (eg, the so-called 'Myers' cocktail') have been promoted in popular culture to 'reduce stress', 'increase energy' or 'boost immunity', with claims that the intravenous route allows faster absorption of vitamins into the bloodstream than if they are taken orally. There is a lack of high-quality evidence to suggest that high-dose vitamin infusions are necessary or offer any health benefit in the absence of a specific vitamin deficiency or medical condition. There may be harms from taking high (non-physiological) quantities of some vitamins and minerals. Licensed forms of injectable vitamins that are prescription-only medicines should not be advertised to the public and should only be supplied and administered by appropriately qualified healthcare professionals.

身体每天需要少量的维生素和矿物质,这些通常是从饮食中获得的。静脉注射维生素用于一些严重的疾病(例如,伴有严重维生素缺乏的吸收不良综合征、韦尼克脑病或危重症)。在流行文化中,含有高剂量各种维生素和矿物质的静脉滴注(如所谓的“迈尔斯鸡尾酒”)已被推广用于“减轻压力”、“增加能量”或“增强免疫力”,并声称静脉滴注比口服更快地将维生素吸收到血液中。缺乏高质量的证据表明,在没有特定维生素缺乏或疾病的情况下,高剂量的维生素输注是必要的,或对健康有益。摄入大量(非生理性)维生素和矿物质可能会带来危害。许可形式的注射维生素是处方药,不应向公众宣传,只能由合格的医疗保健专业人员提供和管理。
{"title":"Intravenous vitamin injections: where is the evidence?","authors":"","doi":"10.1136/dtb.2023.000006","DOIUrl":"10.1136/dtb.2023.000006","url":null,"abstract":"<p><p>The body needs small daily quantities of vitamins and minerals, which are usually obtained from the diet. Intravenous vitamins are used for a few serious medical conditions (eg, malabsorption syndromes with severe vitamin depletion, Wernicke's encephalopathy or critical illness). Intravenous drips containing high doses of various vitamins and minerals (eg, the so-called 'Myers' cocktail') have been promoted in popular culture to 'reduce stress', 'increase energy' or 'boost immunity', with claims that the intravenous route allows faster absorption of vitamins into the bloodstream than if they are taken orally. There is a lack of high-quality evidence to suggest that high-dose vitamin infusions are necessary or offer any health benefit in the absence of a specific vitamin deficiency or medical condition. There may be harms from taking high (non-physiological) quantities of some vitamins and minerals. Licensed forms of injectable vitamins that are prescription-only medicines should not be advertised to the public and should only be supplied and administered by appropriately qualified healthcare professionals.</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"151-155"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10484360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valacyclovir-associated acute kidney injury. 伐昔洛韦相关急性肾损伤。
Q4 Medicine Pub Date : 2023-10-01 Epub Date: 2023-06-30 DOI: 10.1136/dtb.2023.249552rep
James Kirkland, Pathmanathan Suganthan
Summary A man in his 70s presented to hospital with an acute kidney injury. He recently had started taking valacyclovir for treatment of shingles. The valacyclovir was stopped and his acute kidney injury improved. Work-up for other causes of acute kidney injury was negative and he was diagnosed with valacyclovir-associated acute kidney injury. He was discharged home after four days in the hospital with improving renal function.
{"title":"Valacyclovir-associated acute kidney injury.","authors":"James Kirkland,&nbsp;Pathmanathan Suganthan","doi":"10.1136/dtb.2023.249552rep","DOIUrl":"10.1136/dtb.2023.249552rep","url":null,"abstract":"Summary A man in his 70s presented to hospital with an acute kidney injury. He recently had started taking valacyclovir for treatment of shingles. The valacyclovir was stopped and his acute kidney injury improved. Work-up for other causes of acute kidney injury was negative and he was diagnosed with valacyclovir-associated acute kidney injury. He was discharged home after four days in the hospital with improving renal function.","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"156-159"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9746328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug and Therapeutics Bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1